vs
HEALTHY CHOICE WELLNESS CORP.(HCWC)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是HEALTHY CHOICE WELLNESS CORP.的1.0倍($19.6M vs $18.7M),HEALTHY CHOICE WELLNESS CORP.净利率更高(-8.9% vs -177.4%,领先168.5%),HEALTHY CHOICE WELLNESS CORP.自由现金流更多($-927.1K vs $-23.1M)
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
HCWC vs LAB — 直观对比
营收规模更大
LAB
是对方的1.0倍
$18.7M
净利率更高
HCWC
高出168.5%
-177.4%
自由现金流更多
HCWC
多$22.2M
$-23.1M
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $18.7M | $19.6M |
| 净利润 | $-1.7M | $-34.7M |
| 毛利率 | 39.1% | 48.5% |
| 营业利润率 | -7.6% | -168.5% |
| 净利率 | -8.9% | -177.4% |
| 营收同比 | — | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益(稀释后) | $-0.05 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HCWC
LAB
| Q4 25 | $18.7M | — | ||
| Q3 25 | $19.0M | $19.6M | ||
| Q2 25 | $20.2M | $21.8M | ||
| Q1 25 | $20.3M | $40.8M | ||
| Q3 24 | $18.2M | $22.1M | ||
| Q2 24 | — | $22.5M | ||
| Q1 24 | — | $45.5M | ||
| Q4 23 | — | $28.2M |
净利润
HCWC
LAB
| Q4 25 | $-1.7M | — | ||
| Q3 25 | $-1.2M | $-34.7M | ||
| Q2 25 | $-339.4K | $-33.5M | ||
| Q1 25 | $-712.4K | $-26.0M | ||
| Q3 24 | $-2.7M | $-26.9M | ||
| Q2 24 | — | $-45.7M | ||
| Q1 24 | — | $-32.2M | ||
| Q4 23 | — | $-19.8M |
毛利率
HCWC
LAB
| Q4 25 | 39.1% | — | ||
| Q3 25 | 38.8% | 48.5% | ||
| Q2 25 | 40.1% | 48.8% | ||
| Q1 25 | 38.8% | 48.4% | ||
| Q3 24 | 38.4% | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% | ||
| Q4 23 | — | 47.6% |
营业利润率
HCWC
LAB
| Q4 25 | -7.6% | — | ||
| Q3 25 | -3.2% | -168.5% | ||
| Q2 25 | -0.2% | -118.1% | ||
| Q1 25 | -2.0% | -80.8% | ||
| Q3 24 | -2.0% | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% | ||
| Q4 23 | — | -75.9% |
净利率
HCWC
LAB
| Q4 25 | -8.9% | — | ||
| Q3 25 | -6.4% | -177.4% | ||
| Q2 25 | -1.7% | -153.7% | ||
| Q1 25 | -3.5% | -63.8% | ||
| Q3 24 | -14.6% | -122.0% | ||
| Q2 24 | — | -203.3% | ||
| Q1 24 | — | -70.6% | ||
| Q4 23 | — | -70.2% |
每股收益(稀释后)
HCWC
LAB
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.09 | $-0.09 | ||
| Q2 25 | $-0.03 | $-0.09 | ||
| Q1 25 | $-0.07 | $-0.07 | ||
| Q3 24 | $-0.29 | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 | ||
| Q4 23 | — | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $129.4M |
| 总债务越低越好 | $7.3M | — |
| 股东权益账面价值 | $7.3M | $399.7M |
| 总资产 | $33.5M | $539.6M |
| 负债/权益比越低杠杆越低 | 1.00× | — |
8季度趋势,按日历期对齐
现金及短期投资
HCWC
LAB
| Q4 25 | $3.0M | — | ||
| Q3 25 | $3.0M | $129.4M | ||
| Q2 25 | $4.7M | $158.6M | ||
| Q1 25 | $1.8M | $150.9M | ||
| Q3 24 | $1.8M | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M | ||
| Q4 23 | — | $51.7M |
总债务
HCWC
LAB
| Q4 25 | $7.3M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $9.7M | — | ||
| Q1 25 | $10.6M | — | ||
| Q3 24 | $11.6M | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M | ||
| Q4 23 | — | $63.5M |
股东权益
HCWC
LAB
| Q4 25 | $7.3M | — | ||
| Q3 25 | $5.9M | $399.7M | ||
| Q2 25 | $5.8M | $424.5M | ||
| Q1 25 | $2.1M | $454.6M | ||
| Q3 24 | $2.9M | $489.3M | ||
| Q2 24 | — | $510.3M | ||
| Q1 24 | — | $577.3M | ||
| Q4 23 | — | $-148.1M |
总资产
HCWC
LAB
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.7M | $539.6M | ||
| Q2 25 | $36.4M | $557.0M | ||
| Q1 25 | $34.1M | $579.6M | ||
| Q3 24 | $33.2M | $681.5M | ||
| Q2 24 | — | $708.7M | ||
| Q1 24 | — | $777.7M | ||
| Q4 23 | — | $323.1M |
负债/权益比
HCWC
LAB
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.43× | — | ||
| Q2 25 | 1.69× | — | ||
| Q1 25 | 5.01× | — | ||
| Q3 24 | 3.95× | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-855.1K | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-927.1K | $-23.1M |
| 自由现金流率自由现金流/营收 | -5.0% | -118.1% |
| 资本支出强度资本支出/营收 | 0.4% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $675.4K | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
HCWC
LAB
| Q4 25 | $-855.1K | — | ||
| Q3 25 | $-308.7K | $-22.2M | ||
| Q2 25 | $1.1M | $-20.7M | ||
| Q1 25 | $1.1M | $-30.3M | ||
| Q3 24 | — | $-27.9M | ||
| Q2 24 | — | $-39.0M | ||
| Q1 24 | — | $-62.5M | ||
| Q4 23 | — | $-14.1M |
自由现金流
HCWC
LAB
| Q4 25 | $-927.1K | — | ||
| Q3 25 | $-351.3K | $-23.1M | ||
| Q2 25 | $988.6K | $-22.6M | ||
| Q1 25 | $965.3K | $-35.3M | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M |
自由现金流率
HCWC
LAB
| Q4 25 | -5.0% | — | ||
| Q3 25 | -1.8% | -118.1% | ||
| Q2 25 | 4.9% | -103.6% | ||
| Q1 25 | 4.8% | -86.6% | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% |
资本支出强度
HCWC
LAB
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.2% | 4.5% | ||
| Q2 25 | 0.4% | 8.7% | ||
| Q1 25 | 0.6% | 12.4% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCWC
| Retail Grocery | $17.1M | 91% |
| Food Service Restaurant | $1.7M | 9% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |